5CAL | Transferase Transferase Inhibitor | date | Jun 29, 2015 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
title | Egfr Kinase Domain Mutant "Tmlr" With Compound 24 | ||||||||||||||
authors | C.Eigenbrot, C.Yu | ||||||||||||||
compound | source | ||||||||||||||
Molecule: Epidermal Growth Factor Receptor Chain: A Synonym: Proto-Oncogene C-Erbb-1,Receptor Tyrosine-Protein Erbb-1; Ec: 2.7.10.1 Engineered: Yes Mutation: Yes |
Organism_scientific: Homo Sapiens Organism_common: Human Organism_taxid: 9606 Gene: Egfr, Erbb, Erbb1, Her1 Expression_system: Spodoptera Frugiperda Expression_system_taxid: 7108 | ||||||||||||||
symmetry | Space Group: I 2 3 |
| |||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 2.70 Å | ||||||||||||
ligand | 4Z8 | enzyme | Transferase E.C.2.7.10.1 BRENDA | ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | Noncovalent Mutant Selective Epidermal Growth Factor Receptor Inhibitors: A Lead Optimization Case Study., Heald R, Bowman KK, Bryan MC, Burdick D, Chan B, Chan E, Chen Y, Clausen S, Dominguez-Fernandez B, Eigenbrot C, Elliott R, Hanan EJ, Jackson P, Knight J, La H, Lainchbury M, Malek S, Mann S, Merchant M, Mortara K, Purkey H, Schaefer G, Schmidt S, Seward E, Sideris S, Shao L, Wang S, Yeap K, Yen I, Yu C, Heffron TP, J Med Chem. 2015 Nov 25;58(22):8877-95. doi: 10.1021/acs.jmedchem.5b01412. Epub, 2015 Nov 12. PMID:26455919 |
Data retrieval |
View 5CAL in 3D |
Visual 3D analysis of 5CAL |
Structure-derived information |
Sequence-derived information |
Other resources with information on 5CAL |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |